Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
A. Frix (Liege, Belgium), L. Heaney (Belfast, United Kingdom), B. Dahlén (Stockholm, Sweden), F. Mihaltan (Bucharest, Romania), S. Sergejeva (Tartu, Estonia), D. Doberer (Vienna, Austria), S. Popovic-Grle (Zagreb, Croatia), V. Sedlak (Hradec Kralove, Czech Republic), L. Lehtimäki (Tampere, Finland), A. Bourdin (Montpellier, France), S. Korn (Mainz, Germany), E. Zervas (Athens, Greece), Z. Csoma (Budapest, Hungary), D. Lúðvíksdóttir (Reykjavik, Iceland), M. Butler (Dublin, Ireland), G. Canonica (Milan, Italy), I. Grisle (Riga, Latvia), K. Bieksiene (Kaunas, Lithuania), A. Ten Brinke (Leeuwarden, Netherlands), P. Kuna (Lodz, Poland), C. Chaves Loureiro (Coimbra, Portugal), N. Nenasheva (Moscow, Russian Federation), Z. Lazic (Kragujevac, Republic of Serbia), S. Škrgat (Golnik, Slovenia), D. Ramos-Barbon (Coruna, Spain), J. Leuppi (Basel, Switzerland), B. Gemicioglu (Istanbul, Turkey), A. Bossios (Stockholm, Sweden), C. Porsbjerg (Copenhagen, Denmark), E. Bel (Amsterdam, Netherlands), R. Djukanovic (Southampton, United Kingdom), R. Louis (Liège, Belgium)
Source: International Congress 2022 – Asthma biologics in real life studies
Session: Asthma biologics in real life studies
Session type: Thematic Poster
Number: 2397
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Frix (Liege, Belgium), L. Heaney (Belfast, United Kingdom), B. Dahlén (Stockholm, Sweden), F. Mihaltan (Bucharest, Romania), S. Sergejeva (Tartu, Estonia), D. Doberer (Vienna, Austria), S. Popovic-Grle (Zagreb, Croatia), V. Sedlak (Hradec Kralove, Czech Republic), L. Lehtimäki (Tampere, Finland), A. Bourdin (Montpellier, France), S. Korn (Mainz, Germany), E. Zervas (Athens, Greece), Z. Csoma (Budapest, Hungary), D. Lúðvíksdóttir (Reykjavik, Iceland), M. Butler (Dublin, Ireland), G. Canonica (Milan, Italy), I. Grisle (Riga, Latvia), K. Bieksiene (Kaunas, Lithuania), A. Ten Brinke (Leeuwarden, Netherlands), P. Kuna (Lodz, Poland), C. Chaves Loureiro (Coimbra, Portugal), N. Nenasheva (Moscow, Russian Federation), Z. Lazic (Kragujevac, Republic of Serbia), S. Škrgat (Golnik, Slovenia), D. Ramos-Barbon (Coruna, Spain), J. Leuppi (Basel, Switzerland), B. Gemicioglu (Istanbul, Turkey), A. Bossios (Stockholm, Sweden), C. Porsbjerg (Copenhagen, Denmark), E. Bel (Amsterdam, Netherlands), R. Djukanovic (Southampton, United Kingdom), R. Louis (Liège, Belgium). Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study. 2397
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|